Drug Repurposing - Molecular Aspects and Therapeutic Applications [Working Title]

2022 ◽  
Keyword(s):  
Drug Repurposing ◽  
Therapeutic Applications ◽  
Molecular Aspects

Molecular aspects of allergy

2002 ◽  
Author(s):  
S Miescher
Keyword(s):  
Molecular Aspects

Biochemical and Molecular Aspects of the Coagulation Cascade

1995 ◽  
Vol 74 (01) ◽  
pp. 001-006 ◽  
Author(s):  
Earl W Davie
Keyword(s):  
Coagulation Cascade ◽  
Molecular Aspects

Molecular Aspects of Defibrination in a Case of Amniotic Fluid Embolism

1977 ◽  
Vol 38 (03) ◽  
pp. 0724-0727 ◽  
Author(s):  
H Graeff ◽  
R Hafter ◽  
R von Hugo
Keyword(s):  
Amniotic Fluid ◽  
Amniotic Fluid Embolism ◽  
Molecular Aspects

Heparin and proteoglycans as anti-inflammatory drugs

1996 ◽  
Vol 16 (01) ◽  
pp. 56-59
Author(s):  
D. J. Tyrrell ◽  
C. P. Page
Keyword(s):  
Inflammatory Diseases ◽  
Therapeutic Applications ◽  
Wide Range ◽  
Inflammatory Drugs ◽  
Anti Inflammatory

SummaryEvidence continues to accumulate that the pleiotropic nature of heparin (beyond its anticoagulant potency) includes anti-inflammatory activities at a number of levels. It is clear that drugs exploiting these anti-inflammatory activities of heparin may offer exciting new therapeutic applications to the treatment of a wide range of inflammatory diseases.

Felbamate: Clinical and Molecular Aspects of a Unique Antiepileptic Drug

1998 ◽  
Vol 12 (3) ◽  
pp. 205-222 ◽  
Author(s):  
William M. Brown ◽  
Simon P. Aiken
Keyword(s):  
Antiepileptic Drug ◽  
Molecular Aspects

Amorphous Drug Delivery Systems: Molecular Aspects, Design, and Performance

2004 ◽  
Vol 21 (3) ◽  
pp. 133-193 ◽  
Author(s):  
Aditya Mohan Kaushal ◽  
Piyush Gupta ◽  
Arvind Kumar Bansal
Keyword(s):  
Drug Delivery ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
Molecular Aspects ◽  
And Performance ◽  
Amorphous Drug
Sign in / Sign up

Export Citation Format

Share Document